Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Gisslinger, H' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 58 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Worel, N; Greinix, H; Ackermann, J; Kaufmann, H; Urbauer, E; Hocker, P; Gisslinger, H; Lechner, K; Kalhs, P; Drach, J
      Deletion of chromosome 13q14 detected by fluorescence in situ hybridization has prognostic impact on survival after high-dose therapy in patients with multiple myeloma

      ANNALS OF HEMATOLOGY
    2. Heis-Vahidi-Fard, N; Forberg, E; Eichinger, S; Chott, A; Lechner, K; Gisslinger, H
      Ineffectiveness of interferon-gamma in the treatment of idiopathic myelofibrosis: a pilot study

      ANNALS OF HEMATOLOGY
    3. Neunteufl, T; Heher, S; Stefenelli, T; Pabinger, I; Gisslinger, H
      Endothelial dysfunction in patients with polycythaemia vera

      BRITISH JOURNAL OF HAEMATOLOGY
    4. Bachleitner-Hofmann, T; Gisslinger, B; Grumbeck, E; Gisslinger, H
      Arsenic trioxide and ascorbic acid: synergy with potential implications for the treatment of acute myeloid leukaemia?

      BRITISH JOURNAL OF HAEMATOLOGY
    5. Gisslinger, H; Kurzrock, R; Gisslinger, B; Jiang, SW; Li, SR; Virgolini, I; Woloszczuk, W; Andreeff, M; Talpaz, M
      Autocrine cell suicide in a Burkitt lymphoma cell line (Daudi) induced by interferon alpha: involvement of tumor necrosis factor as ligand for the CD95 receptor

      BLOOD
    6. Watzke, IM; Millesi, W; Kermer, C; Gisslinger, H
      Multifocal eosinophilic granuloma of the jaw: Long-term follow-up of a novel intraosseous corticoid treatment for recalcitrant lesions

      ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTICS
    7. Thalhammer-Scherrer, R; Geissler, K; Schwarzinger, I; Chott, A; Gisslinger, H; Knobl, P; Lechner, K; Jager, U
      Fludarabine therapy in Waldenstrom's macroglobulinemia

      ANNALS OF HEMATOLOGY
    8. Konigsberg, R; Ackermann, J; Kaufmann, H; Zojer, N; Urbauer, E; Kromer, E; Jager, U; Gisslinger, H; Schreiber, S; Heinz, R; Ludwig, H; Huber, H; Drach, J
      Deletions of chromosome 13q in monoclonal gammopathy of undetermined significance

      LEUKEMIA
    9. Konigsberg, R; Zojer, N; Ackermann, J; Kromer, E; Kittler, H; Fritz, E; Kaufmann, H; Nosslinger, T; Riedl, L; Gisslinger, H; Jager, U; Simonitsch, I; Heinz, R; Ludwig, H; Huber, H; Drach, J
      Predictive role of interphase cytogenetics for survival of patients with multiple myeloma

      JOURNAL OF CLINICAL ONCOLOGY
    10. Grumbeck, E; Aiginger, P; Gisslinger, B; Geissler, K; Thalhammer-Scherrer, R; Gisslinger, H
      Macrocytic anemia and thrombocytosis associated with thymoma: A case report

      AMERICAN JOURNAL OF HEMATOLOGY
    11. Geissler, K; Gisslinger, H; Knobl, P; Sperr, W; Valent, P; Dieckmann, K; Chott, A; Potter, R; Lechner, K; Jager, U
      Efficacy of standard treatment in patients with Hodgkin's disease - A single center experience

      WIENER KLINISCHE WOCHENSCHRIFT
    12. Schreiber, S; Ackermann, J; Obermair, A; Kaufmann, H; Urbauer, E; Aletaha, K; Gisslinger, H; Chott, A; Huber, H; Drach, J
      Multiple myeloma with deletion of chromosome 13q is characterized by increased bone marrow neovascularization

      BRITISH JOURNAL OF HAEMATOLOGY
    13. Zojer, N; Konigsberg, R; Ackermann, J; Fritz, E; Dallinger, S; Kromer, E; Kaufmann, H; Riedl, L; Gisslinger, H; Schreiber, S; Heinz, R; Ludwig, H; Huber, H; Drach, J
      Deletion of 13q14 remains an independent adverse prognostic variable in multiple myeloma despite its frequent detection by interphase fluorescence insitu hybridization

      BLOOD
    14. Filipits, M; Drach, J; Pohl, G; Schuster, J; Stranzl, T; Ackermann, J; Konigsberg, R; Kaufmann, H; Gisslinger, H; Huber, H; Ludwig, H; Pirker, R
      Expression of the lung resistance protein predicts poor outcome in patients with multiple myeloma

      CLINICAL CANCER RESEARCH
    15. Fiegl, M; Chott, A; Seewann, HL; Lechner, K; Gisslinger, H
      Persisting bone marrow aplasia following interferon-alpha combined with ara-C for chronic myelogenous leukemia

      LEUKEMIA & LYMPHOMA
    16. Meidlinger, P; Knobl, P; Jager, U; Gisslinger, H; Pabinger, I; Weltermann, A; Lechner, K; Geissler, K
      Granulocyte colony-stimulating factor-supported combined immunosuppressivetherapy (antilymphocyte globulin, cyclosporine, and methylprednisolone) inpatients with aplastic anemia: tolerability, efficacy, and changes in the progenitor cell compartment

      ANNALS OF HEMATOLOGY
    17. Fiegl, M; Weltermann, A; Stindl, R; Fonatsch, C; Lechner, K; Gisslinger, H
      Massive disseminated intravascular coagulation and hyperfibrinolysis in alveolar rhabdomyosarcoma: case report and review of the literature

      ANNALS OF HEMATOLOGY
    18. Reiter, E; Kalhs, P; Keil, F; Rabitsch, W; Gisslinger, H; Mayer, G; Worel, N; Lechner, K; Greinix, HT
      Effect of high-dose melphalan and peripheral blood stem cell transplantation on renal function in patients with multiple myeloma and renal insufficiency: a case report and review of the literature

      ANNALS OF HEMATOLOGY
    19. Bachleitner-Hofmann, T; Gisslinger, H
      The role of interferon-alpha in the treatment of idiopathic myelofibrosis

      ANNALS OF HEMATOLOGY
    20. Heis, N; Rintelen, C; Gisslinger, B; Knobl, P; Lechner, K; Gisslinger, H
      The effect of interferon alpha on myeloproliferation and vascular complications in polycythemia vera

      EUROPEAN JOURNAL OF HAEMATOLOGY
    21. Mayr, N; Zeitlhofer, J; Deecke, L; Fritz, E; Ludwig, H; Gisslinger, H
      Neurological function during long-term therapy with recombinant interferonalpha

      JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES
    22. Michiels, JJ; Kutti, J; Stark, P; Bazzan, M; Gugliotta, L; Marchioli, R; Griesshammer, M; van Genderen, PJJ; Briere, J; Kiladjian, JJ; Barbui, T; Finazzi, G; Berlin, NI; Pearson, TC; Green, AC; Fruchtmann, SM; Silver, RT; Hansmann, E; Wehmeier, A; Lengfelder, E; Landolfi, R; Kvasnicka, HM; Hasselbalch, H; Cervantes, F; Reilly, JT; Demory, JL; Gisslinger, H; Guardiola, P; Martyre, MC; Le Bousse-Kerdiles, MC; Thiele, J
      Diagnosis, pathogenesis and treatment of the myeloproliferative disorders essential thrombocythemia, polycythemia vera and essential megakaryocytic granulocytic metaplasia and myelofibrosis

      NETHERLANDS JOURNAL OF MEDICINE
    23. Fureder, W; Weltermann, A; Chott, A; Gisslinger, H; Valent, P; Jager, U; Geissler, K; Lechner, K
      Treatment of hairy cell leukemia with cladribine (2-chlorodeoxyadenosine)

      WIENER KLINISCHE WOCHENSCHRIFT
    24. Lechner, K; Geissler, K; Gisslinger, H
      Polycythaemia vera - Diagnosis and therapy

      WIENER KLINISCHE WOCHENSCHRIFT
    25. Gisslinger, H; Rodeghiero, F; Ruggeri, M; Fard, NHV; Mannhalter, C; Papagiannopoulos, M; Rintelen, C; Lalouschek, W; Knobl, P; Lechner, K; Pabinger, I
      Homocysteine levels in polycythaemia vera and essential thrombocythaemia

      BRITISH JOURNAL OF HAEMATOLOGY
    26. Mitterbauer, G; Winkler, K; Gisslinger, H; Geissler, K; Lechner, K; Mannhalter, C
      Clonality analysis using X-chromosome inactivation at the human androgen receptor gene (HUMARA) - Evaluation of large cohorts of patients with chronic myeloproliferative diseases, secondary neutrophilia, and reactive thrombocytosis

      AJCP. American journal of clinical pathology
    27. FUREDER W; KYRLE PA; GISSLINGER H; LECHNER K
      LOW-MOLECULAR-WEIGHT HEPARIN-INDUCED SKIN NECROSIS

      Annals of hematology
    28. WELTERMANN A; PABINGER I; GEISSLER K; JAGER U; GISSLINGER H; KNOBL P; EICHINGER S; KYRLE PA; VALENT P; SPEISER W; SCHWARZINGER I; MANNHALTER C; LECHNER K
      HYPOFIBRINOGENEMIA IN NON-M3 ACUTE MYELOID-LEUKEMIA - INCIDENCE, CLINICAL AND LABORATORY CHARACTERISTICS AND PROGNOSIS

      Leukemia
    29. STINDL R; FIEGL M; REGELE H; GISSLINGER H; BREITENSEHER MJ; FONATSCH C
      ALVEOLAR RHABDOMYOSARCOMA IN A 68-YEAR-OLD PATIENT IDENTIFIED BY CYTOGENETIC ANALYSIS BONE-MARROW

      Cancer genetics and cytogenetics
    30. WELTERMANN A; MITTERBAUER GJ; MITTERBAUER M; HATTEY E; SPEISER W; GISSLINGER H; KNOBL P; EICHINGER S
      DISSEMINATED INTRAVASCULAR COAGULATION WI TH EXCESSIVE FIBRINOLYSIS IN A PATIENT WITH METASTATIC ENDOMETRIAL CARCINOMA - INFLUENCE OF VARIOUS TREATMENTS ON THE COAGULOPATHY (A CASE-REPORT)

      Wiener Klinische Wochenschrift
    31. Ackermann, J; Meidlinger, P; Zojer, N; Gisslinger, H; Ludwig, H; Huber, H; Drach, J
      Absence of p53 deletions in bone marrow plasma cells of patients with monoclonal gammopathy of undedetermined significance

      BRITISH JOURNAL OF HAEMATOLOGY
    32. DRACH J; ACKERMANN J; FRITZ E; KROMER E; SCHUSTER R; GISSLINGER H; DESANTIS M; ZOJER N; FIEGL M; ROKA S; SCHUSTER J; HEINZ R; LUDWIG H; HUBER H
      PRESENCE OF A P53 GENE DELETION IN PATIENTS WITH MULTIPLE-MYELOMA PREDICTS FOR SHORT SURVIVAL AFTER CONVENTIONAL-DOSE CHEMOTHERAPY

      Blood
    33. GISSLINGER H; KURZROCK R; WETZLER M; TUCKER S; KANTARJIAN H; ROBERTSON B; TALPAZ M
      APOPTOSIS IN CHRONIC MYELOGENOUS LEUKEMIA - STUDIES OF STAGE-SPECIFICDIFFERENCES

      Leukemia & lymphoma
    34. GISSLINGER H
      INTERFERON-ALPHA IN THE THERAPY OF MULTIPLE-MYELOMA

      Leukemia
    35. GISSLINGER H; RINTELEN C; MUSIL N; KNOBL P; LECHNER K; PABINGER I
      ELEVATED LEVELS OF HOMOCYSTEINE IN PATIENTS WITH POLYCYTHEMIA-VERA AND ESSENTIAL THROMBOCYTHEMIA

      Thrombosis and haemostasis
    36. GISSLINGER H; GISSLINGER B; KURZROCK R; GRUMBECK E; TALPAZ M
      THE FAS-LIGAND IS NOT RESPONSIBLE FOR INTERFERON-INDUCED APOPTOSIS INDAUDI CELLS

      Blood
    37. GISSLINGER H; MUSIL N; RINTELEN C; SILLABER C; GISSLINGER B; LECHNER K
      RECOMBINANT INTERFERON-ALPHA IN THE TREATMENT OF POLYCYTHEMIA-VERA

      Blood
    38. MITTERBAUER G; WINKLER K; SCHNEIDER B; GISSLINGER H; GEISSLER K; LECHNER K; MANNHALTER C
      CLONALITY ANALYSIS USING X-CHROMOSOME INACTIVATION AT THE HUMAN ANDROGEN RECEPTOR GENE (HUMARA) - EVALUATION OF PATIENTS WITH CHRONIC MYELOPROLIFERATIVE DISEASES, SECONDARY NEUTROPHILIA AND REACTIVE THROMBOCYTOSIS

      Blood
    39. DRACH J; ACKERMANN J; KROMER E; FRITZ E; SCHUSTER R; GISSLINGER H; ZOJER N; FIEGL N; HEINZ R; LUDWIG H; HUBER H
      SHORT SURVIVAL OF PATIENTS WITH MULTIPLE-MYELOMA AND A P53 GENE DELETION - A STUDY BY INTERPHASE FISH

      Blood
    40. HUHMANN IM; WATZKE HH; GEISSLER K; GISSLINGER H; JAGER U; KNOBL P; PABINGER I; KORNINGER L; MANNHALTER C; MITTERBAUER G; SCHWARZINGER I; KALHS P; HAAS OA; LECHNER K
      FLAG (FLUDARABINE, CYTOSINE-ARABINOSIDE, G-CSF) FOR REFRACTORY AND RELAPSED ACUTE MYELOID-LEUKEMIA

      Annals of hematology
    41. THALHAMMER F; GEISSLER K; JAGER U; KYRLE PA; PABINGER I; MITTERBAUER M; GISSLINGER H; KNOBL P; LACZIKA K; SCHNEIDER B; HAAS OA; LECHNER K
      DURATION OF 2ND COMPLETE REMISSION IN PATIENTS WITH ACUTE MYELOID-LEUKEMIA TREATED WITH CHEMOTHERAPY - A RETROSPECTIVE SINGLE-CENTER STUDY

      Annals of hematology
    42. WEISSEL M; TEMPL E; GISSLINGER H
      INTERFERON-ALPHA INDUCED DISTURBANCES OF THYROID-FUNCTION - A RETROSPECTIVE ANALYSIS OF PUBLISHED AND ORIGINAL DATA

      Acta medica austriaca
    43. GEISSLER K; OHLER L; REITER E; KOLLARS M; GISSLINGER H; ANGELBERGER P; LEIMER M; LECHNER K; VIRGOLINI I
      INTERLEUKIN-10 REGULATES FUNCTION AND SURVIVAL OF HUMAN EOSINOPHILS VIA SPECIFIC BINDING-SITES

      Blood
    44. GISSLINGER H; KURZROCK R; JIANG S; ANDREEFF M; TALPAZ M
      FAS APO-1, ANOTHER INTERFERON-INDUCIBLE GENE

      Blood
    45. GISSLINGER H; RINTELEN C; MANNHALTER C; PABINGER I; GEISSLER K; KNOBL P; EICHINGER S; LECHNER K
      FACTOR-V LEIDEN MUTATION IS NOT A MAJOR CAUSE OF THROMBOTIC TENDENCY IN ESSENTIAL THROMBOCYTHEMIA (ET) AND POLYCYTHEMIA-VERA (PV)

      Blood
    46. FELZMANN T; GISSLINGER H; LUDWIG H
      IMMUNOLOGICAL FINDINGS IN PATIENTS WITH MYELODYSPLASTIC SYNDROME

      Leukemia & lymphoma
    47. FELZMANN T; GISSLINGER H; LUDWIG H
      IMMUNOLOGICAL FINDINGS IN PATIENTS WITH MYELODYSPLASTIC SYNDROME

      Leukemia & lymphoma
    48. WALLNER J; GISSLINGER H; GISSLINGER B; GSUR A; GOTZL M; ZOCHBAUER S; PIRKER R
      MDR1 GENE-EXPRESSION IN CHRONIC LYMPHOCYTIC-LEUKEMIA

      Leukemia & lymphoma
    49. THALHAMMER F; GISSLINGER H; CHOTT A; HAAS O; ETELEHAINZ A; HELBICH T; KUSEC R; LINKESCH W; SIMONITSCH I; STROBL H; LECHNER K; JAGER U
      GRANULOCYTIC SARCOMA OF THE PROSTATE AS THE 1ST MANIFESTATION OF A LATE RELAPSE OF ACUTE MYELOGENOUS LEUKEMIA

      Annals of hematology
    50. BRAND CM; LEADBEATER L; BUDIMAN R; LECHNER K; GISSLINGER H
      SUCCESSFUL RETREATMENT OF AN ANTIINTERFERON RESISTANT POLYCYTHEMIA-VERA PATIENT WITH LYMPHOBLASTOID INTERFERON-ALPHA-N1 AND IN-VITRO STUDIES ON THE SPECIFICITY OF THE ANTIBODIES

      British Journal of Haematology
    51. WETZLER M; KURZROCK R; ESTROV Z; KANTARJIAN H; GISSLINGER H; UNDERBRINK MP; TALPAZ M
      ALTERED LEVELS OF INTERLEUKIN-1-BETA AND INTERLEUKIN-1 RECEPTOR ANTAGONIST IN CHRONIC MYELOGENOUS LEUKEMIA - CLINICAL AND PROGNOSTIC CORRELATES

      Blood
    52. WETZLER M; KURZROCK R; ESTROV Z; KANTARJIAN H; GISSLINGER H; UNDERBRINK MP; TALPAZ M
      ALTERED LEVELS OF INTERLEUKIN-1-BETA AND INTERLEUKIN-1 RECEPTOR ANTAGONIST IN CHRONIC MYELOGENOUS LEUKEMIA - CLINICAL AND PROGNOSTIC CORRELATES

      Blood
    53. GISSLINGER H; KURZROCK R; WETZLER M; ROBERTSON L; KANTARJIAN H; TALPAZ M
      COMPARISON OF APOPTOSIS AND SURVIVAL IN CML AND NORMAL NEUTROPHILS

      Blood
    54. SCHERRER R; GEISSLER K; KYRLE PA; GISSLINGER H; JAGER U; BETTELHEIM P; LACZIKA K; LOCKER G; SCHOLTEN C; SILLABER C; SCHWARZINGER I; THALHAMMER F; LECHNER K
      GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF) AS AN ADJUNCT TO INDUCTION CHEMOTHERAPY OF ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL)

      Annals of hematology
    55. HAUSER I; GISSLINGER H; LOCKER G; ELBL W; KYRLE PA; PABINGER I; LECHNER K
      POSTPARTUM FACTOR-VIII INHIBITORS - REPORT OF 2 CASES WITH SPECIAL REFERENCE TO THE EFFICACY OF VARIOUS TREATMENTS

      Wiener Klinische Wochenschrift
    56. GISSLINGER H; SVOBODA T; CLODI M; GILLY B; LUDWIG H; HAVELEC L; LUGER A
      INTERFERON-ALPHA STIMULATES THE HYPOTHALAMIC-PITUITARY-ADRENAL AXIS INVIVO AND INVITRO

      Neuroendocrinology
    57. FELZMANN T; GISSLINGER H; KRIEGER O; MAJDIC O; LUDWIG H; KOLLER U
      IMMUNOPHENOTYPIC CHARACTERIZATION OF MYELOMONOCYTIC CELLS IN PATIENTSWITH MYELODYSPLASTIC SYNDROME

      British Journal of Haematology
    58. GAIGER A; HENN T; GEISSLER K; GISSLINGER H; LECHNER K; LION T
      QUANTITATIVE PCR ANALYSES IN PATIENTS WITH CHRONIC MYELOID-LEUKEMIA -INCREASE OF BCR-ABL SPECIFIC MESSENGER-RNA EXPRESSION DURING THE PROGRESSION TO BLAST CRISIS

      Blood


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 30/10/20 alle ore 18:03:30